Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma

The findings may have implications for breast cancer surveillance among survivors of Hodgkin lymphoma.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news